Latest / The You Project / #1966 Migraines, Seed Oils, And Profit - David Gillespie
Transcript
- 0:01Speaker 1: I get at it's you project, it's gals Bow, it's cook, Oh,
- 0:04Speaker 1: it's harp so and it's another day on the typ journey.
- 0:09Speaker 1: We're rocketing. We're rocketing towards two thousand episodes. If you've
- 0:13Speaker 1: got an idea what we might do for the two
- 0:15Speaker 1: thousandth t if I was thinking of maybe doing a
- 0:19Speaker 1: live episode with like fifty people or something live recorded
- 0:24Speaker 1: live with people asking what are you looking at me
- 0:26Speaker 1: like that? For? Is that a bad idea?
- 0:27Speaker 2: What do you mean fifty people, fifty people watching?
- 0:31Speaker 1: Not for me? No, no, no, I mean like a live
- 0:32Speaker 1: zoom call where fifty people can sit in the zoom
- 0:35Speaker 1: room like we're doing right now with Golespo, but another
- 0:38Speaker 1: fifty vagabonds.
- 0:40Speaker 2: Oh that would be so fun.
- 0:42Speaker 1: Who can sit in, you know, on mute and then
- 0:44Speaker 1: at a given time ask questions, either type questions through
- 0:48Speaker 1: or ask verbally turning on the old mic.
- 0:51Speaker 2: But how do you pick the fifty?
- 0:54Speaker 1: Well, it's whoever sends us one thousand dollars in small
- 0:57Speaker 1: unmarked bills to No, I don't know, I don't know.
- 0:59Speaker 1: I haven't thought it through. Well, see here's the problem too.
- 1:03Speaker 1: When you do stuff like that, sometimes people go yeah, yeah, yeah,
- 1:07Speaker 1: then they don't show right.
- 1:08Speaker 2: Yeah, and soon they've all got to type stuff in.
- 1:11Speaker 2: I was like, that sounds way more like a Melissa
- 1:13Speaker 2: level of attention to detail than a Tiff Cook.
- 1:17Speaker 1: No, no, no, it's like you can type right now
- 1:20Speaker 1: in the old chat you can write, hey, harps, get
- 1:23Speaker 1: closer to the microphone that never works.
- 1:26Speaker 2: You never listen to that.
- 1:27Speaker 1: I don't read it and I don't listen to you anyway. Calls.
- 1:30Speaker 1: But what do you think we should do for a
- 1:31Speaker 1: thousandth two thousandth?
- 1:34Speaker 3: I don't know. I have very little experience with such things.
- 1:39Speaker 1: So yeah, it's not often you can catch him out
- 1:44Speaker 1: to your visit.
- 1:45Speaker 3: Absolutely no idea. Have you tried asking Ai?
- 1:50Speaker 1: Yeah? Well maybe I asked a tipple to it right now?
- 1:54Speaker 3: If asking Ai, what should a podcast do for the
- 1:58Speaker 3: two thousand episode?
- 2:00Speaker 1: Have you got any ideas too? Yeah?
- 2:03Speaker 3: See what it comes up with.
- 2:07Speaker 1: Oh I just drank some water. Very bad protocol on
- 2:09Speaker 1: the bloody podcast. But who cares? Well whilst she's doing that,
- 2:13Speaker 1: you put up your hand when you've got that. But GILESPO,
- 2:17Speaker 1: welcome back. Thank you so much for joining us as
- 2:20Speaker 1: you do once fortnite. Just so you know David's I
- 2:26Speaker 1: don't know what would you call it? What do you
- 2:27Speaker 1: call raisin Hell?
- 2:28Speaker 3: Is that?
- 2:29Speaker 1: What just were your I was going to say suppository.
- 2:33Speaker 1: What I meant was repository.
- 2:34Speaker 3: Repository.
- 2:35Speaker 1: Yes, yeah, David's suppository of quality work. No, his repository
- 2:42Speaker 1: of articles. Is Is it raisinhell dot com?
- 2:46Speaker 3: Is it on? No? No, it's just on substack and
- 2:49Speaker 3: in search for which search for raisin Hell on substack.
- 2:54Speaker 1: And that is R A I S I N hble
- 2:58Speaker 1: l if have you got any gold for us? Have
- 3:02Speaker 1: you got any wisdom?
- 3:04Speaker 3: The reverse?
- 3:04Speaker 1: The creative Genius.
- 3:06Speaker 2: Flip the mic two thousand and two thousand, Rapid Fire
- 3:10Speaker 2: Wisdom two thousand seconds, where you give your twenty most
- 3:13Speaker 2: powerful lessons from two thousand episodes. Audience in the room
- 3:20Speaker 2: many a bit mare.
- 3:22Speaker 3: Maybe you need to Maybe you need to give it
- 3:24Speaker 3: a bit more context iff and tell it what the
- 3:26Speaker 3: show is about. It might be able to do better.
- 3:28Speaker 2: Chatters knows everything about my life, man. Chatters are best mates.
- 3:31Speaker 1: You know.
- 3:32Speaker 2: Chatters knows all about heart.
- 3:34Speaker 1: That's true. If I asked my Chatters, it would say
- 3:36Speaker 1: something different because it and my are besties. Although we
- 3:39Speaker 1: did have a fight.
- 3:40Speaker 2: The other day, Oh, harps in the hot seat, the
- 3:43Speaker 2: uncensored roast and therapy session.
- 3:46Speaker 3: There we go.
- 3:47Speaker 1: Don't need you, Yeah, we don't need that. Already got
- 3:52Speaker 1: enough issues. I'm already in therapy three times a week.
- 3:57Speaker 1: All right, gillespo, welcome back to the show. As I said,
- 4:02Speaker 1: so you wrote an article. There was a new one
- 4:05Speaker 1: out today which I haven't read yet, apologize, but you
- 4:08Speaker 1: wrote one about a week ago, I would think now
- 4:10Speaker 1: called Engineered for Pain, the Untold Story of Migraine, seed,
- 4:15Speaker 1: oils and profit. And yeah, that's a really good article. Everyone,
- 4:19Speaker 1: if you want to go, have a read of it.
- 4:21Speaker 1: But if you can't be bothered, just tune in right
- 4:23Speaker 1: now because the Great Man is going to give us
- 4:25Speaker 1: a little bit of a reader's digest version of what
- 4:28Speaker 1: that was about.
- 4:30Speaker 3: So have you have you ever suffered from migraine? Set all?
- 4:35Speaker 1: I have. I've been very lucky. I don't know why,
- 4:37Speaker 1: but yeah, I do have friends who absolutely crippled by them.
- 4:43Speaker 1: And yeah, hole got to be in a dark room,
- 4:46Speaker 1: eyes closed, no noise, no movement. Yeah, so it's I
- 4:51Speaker 1: personally can't understand, but I've been around it very debility.
- 4:54Speaker 3: Yeah, I've been around it quite a bit, because my
- 4:56Speaker 3: wife has had them at quite bad at time in
- 5:00Speaker 3: her life, and some of my kids have as well.
- 5:03Speaker 3: If you ever had migraines.
- 5:05Speaker 2: Yeah, I got them monthly when I hit adolescents for
- 5:09Speaker 2: a period of time was horrible.
- 5:12Speaker 3: There's a good reason for that, and we're going to
- 5:14Speaker 3: talk about that a little bit.
- 5:16Speaker 1: How long did they last? How long? Sorry, David, how
- 5:18Speaker 1: long did they last?
- 5:19Speaker 2: They were brutal. They were usually just twenty four hours,
- 5:23Speaker 2: but I would vomit like literally every hour on the hour,
- 5:28Speaker 2: and then that would just slowly pit her out longer
- 5:31Speaker 2: and longer.
- 5:31Speaker 3: It was.
- 5:32Speaker 1: Was it exactly when you got your period or was
- 5:34Speaker 1: it just during that time?
- 5:36Speaker 2: It was the few months before it was leading up
- 5:38Speaker 2: to that time, because but I remember the school, my
- 5:41Speaker 2: school teacher, one of my school teachers. I kept going
- 5:43Speaker 2: home once a month and they said then they just
- 5:47Speaker 2: started asking me if you got your period yet? I
- 5:48Speaker 2: think this might be hormonal.
- 5:51Speaker 1: Yeah, it was horrible, horr Right, So when you got
- 5:55Speaker 1: your period that stopped?
- 5:57Speaker 2: Yeah?
- 5:58Speaker 3: Yeah, oh yeah, it is interesting. We might talk a
- 6:02Speaker 3: little bit about why that might be. But let's migrains
- 6:07Speaker 3: affect an awful lot of people, and they aren't just
- 6:10Speaker 3: headaches there, you know, as Tiff described, really crippling can
- 6:15Speaker 3: be for sort of up to twenty four hours, and
- 6:18Speaker 3: they can be multiple times a month. I mean TIFFs
- 6:21Speaker 3: were just once a month. But people can who suffer
- 6:25Speaker 3: from this, and it is a lot of people. You know,
- 6:28Speaker 3: it is debilitating and you know it can affect their career,
- 6:32Speaker 3: can affect their job because it just can't work. You
- 6:34Speaker 3: can't go to work, you know, you can't look after kids,
- 6:38Speaker 3: you can't do anything. And so it's been, as you
- 6:42Speaker 3: might imagine, a bit of a priority for the drug
- 6:45Speaker 3: makers to come up with something that they can do
- 6:47Speaker 3: about it, because you know, panodole and neurophin and so
- 6:53Speaker 3: on just aren't going to do anything for you. If
- 6:55Speaker 3: you would have experienced that taking a couple of panadol
- 6:59Speaker 3: would done much for your migraine. It's just something you
- 7:01Speaker 3: have to work through, right ye. Yeah. And there's a
- 7:07Speaker 3: good reason for it, because there's a lot more going
- 7:09Speaker 3: on than just a headache. The headache sort of the
- 7:11Speaker 3: final bit of what's going on. It starts with what
- 7:15Speaker 3: they call, you know, sort of a spreading well, well
- 7:20Speaker 3: they call it a CSDE or cortical spreading depression, which
- 7:23Speaker 3: is just a wave of electrical activity in the brain,
- 7:27Speaker 3: which often is what causes the aura that a lot
- 7:29Speaker 3: of people describe. So they get an aura before the
- 7:33Speaker 3: pain where you know, and they know it's coming, so
- 7:36Speaker 3: that it's not yet hurting, but they know it's about
- 7:39Speaker 3: to hit, and that probably makes it even scarier. But
- 7:43Speaker 3: I guess it gives them warning to get into a
- 7:46Speaker 3: dark room, calm down, stay out of the way of
- 7:49Speaker 3: noise and light and so on. But what's going on
- 7:53Speaker 3: in a migraine has probably since the early nineties started
- 7:58Speaker 3: to be a lot clearer since they discovered some of
- 8:01Speaker 3: the peptides that were involved in the brain, and in
- 8:04Speaker 3: particular one called CGRP, which I won't bother digging out.
- 8:09Speaker 3: People can read the articles that are interested in it.
- 8:11Speaker 3: But CGRP is important because the drug companies have found
- 8:16Speaker 3: that they can suppress the impact of CGRP. So CGRP
- 8:20Speaker 3: seems to be critically involved in the pain mechanism, so
- 8:25Speaker 3: the spreading pain inside the brain, So just to be
- 8:30Speaker 3: sure to be clear on what's going on, CGRP is
- 8:34Speaker 3: what's known as a vasodilator, so it dilates the veins
- 8:40Speaker 3: the blood vessels in the brain, particularly around the edge
- 8:43Speaker 3: of the brain the Meninji's and widens and causes the throbbing,
- 8:49Speaker 3: pulsating pain that's associated with migraines. Now, the drug companies,
- 8:56Speaker 3: as soon as they found that, started working on are
- 8:58Speaker 3: there things we can do to block CGRP, like, you know,
- 9:03Speaker 3: can we interfere with the receptors for CGRP and the brain,
- 9:06Speaker 3: et cetera, et cetera. Working on a lot. In the
- 9:09Speaker 3: last decade or so, some powerful drugs have come out
- 9:13Speaker 3: which do exactly that. So those drugs actually counteract CGRP
- 9:21Speaker 3: in the brain and the result is that people who
- 9:26Speaker 3: are given these drugs experience two to two and a
- 9:32Speaker 3: half less migraine days per month, which is a significant impact.
- 9:37Speaker 3: It's way beyond anything you know, anyone's ever managed before
- 9:41Speaker 3: with any sort of standard pain killer, because it's not
- 9:43Speaker 3: actually a painkiller, it's it's targeting the exact cares and
- 9:49Speaker 3: so for that reason, it's powerful. It works. We know
- 9:53Speaker 3: it works, and these drugs are now obviously finding themselves
- 9:58Speaker 3: a very very big mark because this is something that impacts,
- 10:02Speaker 3: you know, large percentages of the workforce. What's all this
- 10:07Speaker 3: got to do with seag oils. The interesting thing is
- 10:13Speaker 3: that you might say, Okay, well, that's all fabulous information
- 10:17Speaker 3: about the CGRPs and how that impacts the brain, and
- 10:19Speaker 3: it's great that we've got drugs that work on them,
- 10:22Speaker 3: But what causes the CGRPs to be there in the
- 10:25Speaker 3: first place is the more interesting question. What causes people
- 10:29Speaker 3: to have that reaction, what causes them to need a
- 10:31Speaker 3: drug to counteract them, And that's where some really interesting
- 10:36Speaker 3: research has been done on what's called oxylipands, which are
- 10:39Speaker 3: sort of precursors to the CGRPs, and in particular ones
- 10:45Speaker 3: which are created from amiga six fats. Now amiga six fats,
- 10:50Speaker 3: you will remember, so we've talked before about seed oils,
- 10:52Speaker 3: so things like carnola oil, sunflower oil, you know what
- 10:59Speaker 3: is generally disc as vegetable oil on the label of foods,
- 11:02Speaker 3: you know, but no vegetables were harmed in the creation.
- 11:05Speaker 3: They're actually fats that are created from seeds. So there's
- 11:10Speaker 3: three classes of oil. There's animal fats, there's seed fats,
- 11:17Speaker 3: and there's oil that you put in your car mineral
- 11:22Speaker 3: from minerals. So vegetable oils largely created from seeds. Some flowers, aflower, canola,
- 11:29Speaker 3: et cetera. All of them are very very high in
- 11:33Speaker 3: AMEGA six polyunsaturated fats. And one of the problems is
- 11:39Speaker 3: that the rate of growth in migraines, So migraines have
- 11:44Speaker 3: increased in the population since nineteen ninety, since they started
- 11:49Speaker 3: counting this sort of thing, by almost sixty percent. So
- 11:53Speaker 3: since nineteen ninety, the incidence of migraine in the population
- 11:59Speaker 3: has increased by almost sixty percent. So something's going on
- 12:05Speaker 3: in the environment. And the interesting thing, and what prompted
- 12:09Speaker 3: me to write this piece is that I saw I
- 12:12Speaker 3: came across, just quite by chance, a really excellent piece
- 12:15Speaker 3: of research. In nutrition science, you rarely see really high
- 12:20Speaker 3: quality research. It's usually sort of, you know, associative type stuff.
- 12:24Speaker 3: You know, men who have big cars, you know, have headaches,
- 12:30Speaker 3: and Tiff was going somewhere else with that one, but
- 12:32Speaker 3: you know that sort of like associating two things and
- 12:35Speaker 3: saying these two things correlate, therefore one causes the other.
- 12:39Speaker 3: That's the kind of research you tend to get in
- 12:41Speaker 3: nutrition because doing any other kind of research and nutrition
- 12:44Speaker 3: is really really hard. It's hard to do a double
- 12:46Speaker 3: blind trial in nutrition because you know, the person knows
- 12:51Speaker 3: whether they're eating a steak or whether they're eating ice cream,
- 12:54Speaker 3: so you tend to get mostly rubbish. But there was
- 12:58Speaker 3: this really really high quality done targeting this question, published
- 13:05Speaker 3: in the British Medical journal, very good publication. The people
- 13:08Speaker 3: doing the trial was the National Institute's of Health in
- 13:11Speaker 3: the United States, in particular a fellow by the name
- 13:14Speaker 3: of Chris Ramsden who has been assigned as there for
- 13:17Speaker 3: decades and has been looking at amiga six fats for
- 13:20Speaker 3: a long time, and he asked the question, is there
- 13:23Speaker 3: a way we could run a trial to show whether
- 13:26Speaker 3: or not amiga six fats in some way implicated in
- 13:30Speaker 3: this massive rise in migraines. And what he did was
- 13:34Speaker 3: organized exactly that. So he broke a trial group of
- 13:38Speaker 3: people into three groups. One group ate exactly the way
- 13:43Speaker 3: they always did, nothing unusual. The second group was asked
- 13:46Speaker 3: to increase the amount of fish they ate, so therefore
- 13:49Speaker 3: increased the Amega three in their diet. And the third
- 13:52Speaker 3: group were asked to do that and swap out all
- 13:57Speaker 3: the vegetable oils and seed oils in their diet instead
- 14:00Speaker 3: of using sunflowl oil or canol oils, which olive oil
- 14:03Speaker 3: or animal fats and intentionally avoid seed oils in the diet.
- 14:07Speaker 3: And it reduced the amount of Amega six containing fats
- 14:11Speaker 3: they were consuming by about a third, sorry, so by
- 14:14Speaker 3: about two thirds. So I dropped them from seven percent
- 14:17Speaker 3: of calories to two percent of calories. So it was
- 14:21Speaker 3: a fairly effective trial. It ran for sixteen weeks. All
- 14:24Speaker 3: of them were pre screened to be migraine sufferers. The
- 14:27Speaker 3: effects in the group that dropped the Amega six were
- 14:31Speaker 3: truly massive. Now remember that what I said before about
- 14:35Speaker 3: the drugs. The most powerful drug that's ever been invented,
- 14:39Speaker 3: took out two and a half migraine days per month. Yes,
- 14:44Speaker 3: the group that all they did, they didn't do anything else.
- 14:47Speaker 3: They just stopped consuming Amega three sorry Amega six fats,
- 14:51Speaker 3: so stopped consuming seed oils. Four less migraine days per month.
- 14:59Speaker 1: That's bloody, I mean, no.
- 15:01Speaker 3: Drugs, nothing. All they did was reduced the amount of
- 15:05Speaker 3: seed oils they consumed and they got four less days
- 15:11Speaker 3: per month. Now, I came across this because I happened
- 15:15Speaker 3: to see it in a story in the New York
- 15:17Speaker 3: Times about this trial, and the story featured the lady
- 15:21Speaker 3: that I put in my article, which was. She was
- 15:23Speaker 3: one of the participants in the trial. This is now
- 15:26Speaker 3: three years late after the trial. The trial was completed
- 15:28Speaker 3: in twenty twenty one and published I think in twenty
- 15:31Speaker 3: twenty two, and she's been doing it ever since. She said,
- 15:35Speaker 3: there's no way I am going back to eating the
- 15:37Speaker 3: way I was, because I've been paying free now for
- 15:40Speaker 3: years and never been paying free my entire life. She's
- 15:42Speaker 3: fifty eight.
- 15:43Speaker 1: Wow.
- 15:45Speaker 3: And this accords with something that I've seen mentioned every
- 15:50Speaker 3: now and then by people who follow paleo diets. Quite
- 15:55Speaker 3: by accident. Part of the paleo diet is you tend
- 15:59Speaker 3: to eat animal fats and avoid seed oils. And a
- 16:04Speaker 3: lot of people have sort of anecdotally said you see
- 16:07Speaker 3: it in the chat groups and sign people say, oh,
- 16:08Speaker 3: I haven't had migraines since I stopped started eating this way.
- 16:12Speaker 3: You know, has anyone else experience that? And a lot
- 16:14Speaker 3: of people say, yeah, actually I have, And it accords
- 16:17Speaker 3: with my own experience from the moment we stopped eating
- 16:21Speaker 3: seed oils. As a household, my wife has not had
- 16:24Speaker 3: a migraine, my kids have not had migraines. So that's
- 16:30Speaker 3: all mabulous.
- 16:31Speaker 1: How long has that, mate, overwhell.
- 16:35Speaker 3: I put toxic oil. The book I wrote about this
- 16:37Speaker 3: out in twenty fourteen, so that's yeah, so that's over
- 16:41Speaker 3: eleven ten years now and the hang on, no.
- 16:48Speaker 1: I just I want to ask a couple of questions.
- 16:50Speaker 1: So sorry, So that's eleven years. That's fucking amazing. On
- 16:54Speaker 1: how often was your wife having migraines?
- 16:58Speaker 3: Ah, look, I'd say it to a couple of time. Times
- 17:00Speaker 3: a month. Would have been a couple of times a month.
- 17:02Speaker 1: Yeah, so she was having give or take twenty to
- 17:05Speaker 1: twenty five migraines a year and hasn't had one migraine
- 17:09Speaker 1: in any year, no sense, that's incredible. And yeah, that's incredible.
- 17:17Speaker 3: The interesting thing about this is this is the first
- 17:20Speaker 3: time I've seen real high quality evidence about this. So
- 17:25Speaker 3: this is one of those things where drug companies have
- 17:27Speaker 3: been really interested in it because as soon as they
- 17:30Speaker 3: discovered something you could you know, nail you could hit
- 17:32Speaker 3: with a hammer, which is the CGRP, they said, well,
- 17:35Speaker 3: there's a drug target, let's do that. Yes, but they
- 17:38Speaker 3: stopped there thinking there, Well, this research has done. They said, okay,
- 17:42Speaker 3: but where's the CGRP come from? And this is where
- 17:46Speaker 3: they've dug into the mechanism and said, what's really going
- 17:49Speaker 3: on here is that Amiga six fats, uniquely a Mega
- 17:53Speaker 3: six fats. These are the only things that can do
- 17:55Speaker 3: it create a precursor to CGRP prostaglandin or it's a
- 18:02Speaker 3: class of oxylipins which causes the CGRP to be created.
- 18:10Speaker 3: And they've said, what if we took the A Mega
- 18:12Speaker 3: six fats out, what would happen? Their theory was, what
- 18:15Speaker 3: would happen is it's stopped migraines. Turns out they're right,
- 18:20Speaker 3: So there is a very simple solution here. Now, as
- 18:25Speaker 3: with all things about seed oils, there's always going to
- 18:27Speaker 3: be people to have a propensity for the particular condition
- 18:30Speaker 3: no matter what, and there'll be people who try this
- 18:32Speaker 3: and they still get migraines. Maybe not as many, but
- 18:35Speaker 3: they still get them. But what this shows is that
- 18:39Speaker 3: the non drug based solution to this is more powerful
- 18:47Speaker 3: than even the most powerful drug based solution, the miraculous
- 18:51Speaker 3: one that they've already released. And I just find that fascinating.
- 18:57Speaker 3: So the full write up, as you say, is in
- 18:59Speaker 3: that is in that post and people can go and
- 19:02Speaker 3: look at the read the article if they want to
- 19:04Speaker 3: read the study if they're interested in that funny?
- 19:07Speaker 1: Isn't that funny? How? Okay, So you've known this for
- 19:10Speaker 1: at least eleven years, and I'm sure a lot of
- 19:12Speaker 1: other people have known it. How I mean, I've been
- 19:17Speaker 1: in and around health, wellness, fitness, owning gyms, blah blah blah.
- 19:21Speaker 1: I've never heard of this like this is like, I mean,
- 19:25Speaker 1: until I saw the article, Like have you ever heard
- 19:27Speaker 1: of this tip? Like, isn't it funny that there's something
- 19:33Speaker 1: that's basically twice as good as the best drug? But
- 19:37Speaker 1: it's not making any one money? Right, So it's not
- 19:42Speaker 1: it's you know, it doesn't get you know, for whatever reason.
- 19:46Speaker 1: But it would seem to me there's a correlation there,
- 19:48Speaker 1: and that's a that's a very inconvenient truth for a
- 19:50Speaker 1: lot of people who are trying to sell the drug
- 19:52Speaker 1: that works half as well as removing Mega six oils
- 19:55Speaker 1: from you.
- 19:56Speaker 3: But significantly better than any other drug. I mean, you know,
- 20:01Speaker 3: with good reason. It is put forward as a miracle,
- 20:05Speaker 3: and it is as far as drug goes. What this
- 20:08Speaker 3: is study is telling us is, yeah, that's great, but
- 20:11Speaker 3: we can do even better than that without the drug. Now,
- 20:16Speaker 3: just before, just before we go on. I just wanted
- 20:18Speaker 3: to mention the thing I said to Tiff before we
- 20:20Speaker 3: might talk about the reason why so migrains disproportionately affect women.
- 20:26Speaker 3: It's the leading cause of disability for women under fifty.
- 20:31Speaker 3: And the under fifty bit is important there because they're
- 20:35Speaker 3: the women who are likely to be having periods. And
- 20:38Speaker 3: we know that estrogen plays a key role in the
- 20:44Speaker 3: pathway that influences the release of CGRP. So there's particular
- 20:50Speaker 3: parts of the menstrual cycle and pregnancy and menopause that
- 20:54Speaker 3: can provide really predictable cycles of vulnerability. So we know that.
- 21:02Speaker 3: The other interesting thing we know is that men are
- 21:04Speaker 3: catching up really really fast.
- 21:07Speaker 1: So is that because men have got more and more
- 21:10Speaker 1: estrogen and less testosterone?
- 21:12Speaker 3: No, no, I wish, I wish I could come up
- 21:14Speaker 3: with you a spectacular acclaim as that for you, Craig,
- 21:18Speaker 3: But unfortunately it just means that we're now eating so
- 21:21Speaker 3: much seed oil that it's overwhelming that the limited defense
- 21:25Speaker 3: is the testosterone play, right, So testosterone waters down the
- 21:29Speaker 3: effect and we're overcoming that by the amount of seed
- 21:33Speaker 3: oil that we're consuming.
- 21:35Speaker 1: Yeah. Yeah, Now, just there's some people who are new
- 21:39Speaker 1: to you and new to the show and they're going,
- 21:42Speaker 1: fucking he fuck, this is the best thing I've ever heard,
- 21:45Speaker 1: because my sister, my son, my daughter, my cousin, my boss,
- 21:48Speaker 1: my employee needs to know.
- 21:50Speaker 3: This.
- 21:51Speaker 1: Just remind everyone what what the seed oils are?
- 21:56Speaker 3: Oil? Yeah, yeah, Well, basically, if you go onto a
- 21:59Speaker 3: supermarket and it says vegetable oil on the label, it's
- 22:02Speaker 3: probably a seed oil. So the seed oils are oils
- 22:06Speaker 3: that come from seed, so canola seeds, stoy bean, which
- 22:09Speaker 3: is a legume but let's just go with that, and peanuts, almonds, sunflowers, safflower.
- 22:20Speaker 3: I think I probably missed one or two, but you
- 22:22Speaker 3: get the gear, the drift the ones that aren't. So
- 22:25Speaker 3: there's a couple of vegetables which aren't seed oils, and
- 22:28Speaker 3: that is olive oil. And so these as a class
- 22:31Speaker 3: are what I would call fruit oils. So olive is
- 22:33Speaker 3: a fruit, so is coconut, so coconut oil, olive oil,
- 22:37Speaker 3: palm oil. Palm is a fruit as well. So those
- 22:40Speaker 3: three are described as vegetable oils as well, but they
- 22:45Speaker 3: are generally fine because they're quite low in a Mega
- 22:49Speaker 3: six m.
- 22:52Speaker 1: It's funny. The other day I went into the old
- 22:54Speaker 1: soupy to try and find some of the world famous
- 22:57Speaker 1: Gillespie good fat I think it's called good fat mayo.
- 23:02Speaker 1: Is that the one? Yeah?
- 23:03Speaker 3: Yeah, that's the one. Yeah, yeah, ye know that.
- 23:04Speaker 1: It's in that short squat yes, round, of course, it's round,
- 23:09Speaker 1: but it's it's it's like a really relatively small jar
- 23:13Speaker 1: and it's like twenty bucks.
- 23:15Speaker 3: You know, you can just make it yourself.
- 23:17Speaker 1: Right yeah? Yeah? Have you seen me so olive oil?
- 23:21Speaker 3: Done? Yeah?
- 23:23Speaker 1: But how long is that? Isn't it going to go ranswerd.
- 23:26Speaker 3: After a week? Do you not eat much mayo?
- 23:29Speaker 1: Not a lot, but I like having a bit of mayo.
- 23:32Speaker 1: But like the what's hilarious is like the seed oil
- 23:35Speaker 1: version is like fucking five bucks for gallon. The olive
- 23:40Speaker 1: oil stuff is like it's like trying to buy gold.
- 23:45Speaker 1: It's like a little jar as twenty dollars and a
- 23:48Speaker 1: big jar of the other one, who's five dollars. I'm like,
- 23:51Speaker 1: even just this has got to be some kind of
- 23:54Speaker 1: indication of what's in there, you know.
- 23:57Speaker 3: Yeah, well, I mean olive oil is a little bit
- 24:00Speaker 3: more expensive than sunflower oil, which is what's being used
- 24:03Speaker 3: in the other ones, but it's not that much more expensive.
- 24:06Speaker 3: It's just you know what the market can bear.
- 24:10Speaker 1: Yeah, yeah, all right. So so that what's that one
- 24:14Speaker 1: that you said as a precursor to CGRP.
- 24:19Speaker 3: So the oxylipans, So there's both the Mega three and
- 24:23Speaker 3: the a Mega six X and Mega three's are the
- 24:25Speaker 3: ones that reduce pain, a Mega six increases pain. They
- 24:28Speaker 3: produce things called oxylipins, and the oxylipants from a Mega
- 24:34Speaker 3: six proster gland, and being one of them is one
- 24:37Speaker 3: of the important precursors to CGRP.
- 24:42Speaker 1: I mean, obviously, everyone, none of this is medical advice.
- 24:45Speaker 1: None of us are medical professionals. But like, let me
- 24:49Speaker 1: just say this. If I suffered from migraines on a
- 24:53Speaker 1: semi regular basis, I would do an N equals one,
- 24:57Speaker 1: you know, study of one. That's me go, I'm going
- 25:00Speaker 1: to do this for thirty days and see what happens.
- 25:04Speaker 1: I can have any omega six, no seed oils. I'm
- 25:09Speaker 1: just going to do.
- 25:10Speaker 3: You know, So if you're wanting to do this, If
- 25:12Speaker 3: you're wanting to do this, how would it look practically?
- 25:15Speaker 3: First of all, you chuck out all the seed oils,
- 25:17Speaker 3: wouldn't cook in them, right, So you'd throw out your
- 25:19Speaker 3: spray t in that you use to spray on your
- 25:21Speaker 3: pan of canola oil or whatever. You'd swap out to
- 25:25Speaker 3: olive oil or something in your kitchen if you're doing
- 25:27Speaker 3: any cooking, you wouldn't buy anything fried. You wouldn't buy
- 25:30Speaker 3: anything that's crispy from a supermarket so because that's probably
- 25:34Speaker 3: been fried as well. So biscuits, you know, yeah, chips,
- 25:38Speaker 3: things like that. You wouldn't buy any of those things
- 25:41Speaker 3: that have been fried. And you wouldn't buy dips because
- 25:44Speaker 3: they're all some four. You wouldn't buy commercial mayo, et cetera,
- 25:47Speaker 3: because you wouldn't buy sandwiches from a sandwich shop because
- 25:49Speaker 3: they're using margarine made from seed oil. But you eliminate
- 25:52Speaker 3: all those obvious sources of seed oil, you would massively
- 25:56Speaker 3: cut the amount of a mega six you're consuming. And
- 25:59Speaker 3: I reckon if you and that I mean in this
- 26:01Speaker 3: trial they did it for sixteen weeks. I reckon if
- 26:04Speaker 3: you ran it for a couple of months, you'd have
- 26:07Speaker 3: noticeable impact. This study says you would see a measurable impact.
- 26:13Speaker 1: And so that researcher, his name is Chris Ramsden, and
- 26:17Speaker 1: it was with BMJ British Medical Journal that's right.
- 26:20Speaker 3: I think in the article yep.
- 26:22Speaker 1: Great, great, great, that's all I wanted to know, because
- 26:25Speaker 1: I want to go read that. That's amazing. Well, you know,
- 26:29Speaker 1: it's good that people have got something to try. You know,
- 26:33Speaker 1: it's good that people can you know, share this and
- 26:36Speaker 1: perhaps take it for a test drive and see what happens.
- 26:41Speaker 1: The other thing of not only interest but fascination that
- 26:45Speaker 1: we spoke about our fair was that an organization that
- 26:49Speaker 1: I've never heard of called the National Crime Institute. Didn't
- 26:52Speaker 1: even know.
- 26:53Speaker 3: It's the Australian Criminal Intelligence Commission, Well the ac I see.
- 26:58Speaker 3: I know I called it the National Mischue when we're
- 27:00Speaker 3: talking off here, but I've actually looked it up since.
- 27:03Speaker 1: Right, all right whatever, Still haven't heard of that. But
- 27:06Speaker 1: they they've been looking into our pooh and Wi. Let's
- 27:09Speaker 1: be honest, that's gross. They've been analog look at TIFFs face,
- 27:14Speaker 1: they've been analyzing TIFFs, pooh and Wi, and what have
- 27:17Speaker 1: they come up with?
- 27:19Speaker 3: Well, so they had They didn't just do it yesterday either,
- 27:22Speaker 3: They've been doing it for ten years. So there's been
- 27:25Speaker 3: a thing called the National Wastewater Drug Monitoring Program.
- 27:29Speaker 1: So so good. How's your soup? Looking nounceive.
- 27:35Speaker 2: Haven't eaten Dinny either.
- 27:37Speaker 1: I hope you're not having any kind of casserole.
- 27:42Speaker 3: So they have figured that the best way to figure out,
- 27:45Speaker 3: you know that there's all sorts of ways to figure
- 27:47Speaker 3: out what drugs people are taking, right, what illicit substances
- 27:50Speaker 3: people are taking. One of them being to ask them.
- 27:53Speaker 3: But you know, surprisingly people are less than honest when
- 27:58Speaker 3: it comes to such things. So they say, well, maybe
- 28:02Speaker 3: we'll get more accurate numbers if we don't ask them,
- 28:06Speaker 3: but just check out what's going down the toilet. And
- 28:11Speaker 3: so there's been this program in place for ten years
- 28:13Speaker 3: and it is in hundreds of sites around the country
- 28:17Speaker 3: where they measure all kinds of drugs in the wastewater
- 28:22Speaker 3: from the waste systems of you know, the water treatment
- 28:25Speaker 3: plants all around the country. So everywhere there's a water
- 28:27Speaker 3: treatment plant, there's one of these things measuring what's in it.
- 28:32Speaker 1: And that would be before it's been filtered or whatever
- 28:37Speaker 1: they do treated.
- 28:39Speaker 3: I'm not entirely across them. Well, it would certainly be
- 28:41Speaker 3: before it's treated, because the point would be to get
- 28:45Speaker 3: it in the wild. If you like, Yeah.
- 28:47Speaker 1: Well it's essentially pooh, and why you soup, isn't it.
- 28:50Speaker 1: Let's be honest. I mean, it's just well, but what
- 28:53Speaker 1: what do you think it is?
- 28:59Speaker 3: Visceral It's his job as a podcast to bring in
- 29:02Speaker 3: the audience into the room with them.
- 29:04Speaker 1: I'm just trying to paint a picture for the peeps.
- 29:09Speaker 1: Shout out to those having a little savaloi casserole tonight.
- 29:12Speaker 3: So I look, I can recommend the entire report because
- 29:17Speaker 3: it is riveting stuff because it actually goes through all
- 29:22Speaker 3: the big contenders for addictive substances, and they're measuring them
- 29:26Speaker 3: all and have been measuring them for over ten years now.
- 29:29Speaker 3: So you know, things like nicotine, how much are people
- 29:32Speaker 3: actually consuming from all sources, So this would be it'd
- 29:36Speaker 3: be ending up in there, whether it comes from a
- 29:38Speaker 3: patch or from cigarettes or from you know, the stuff
- 29:43Speaker 3: you got in your arms or whatever. So answer is
- 29:46Speaker 3: hasn't changed in ten years. So the amount of nicotine
- 29:50Speaker 3: ending up in the wastewater has not changed. Their smoking
- 29:53Speaker 3: rates have dropped, but the amount of nicotine ending up
- 29:57Speaker 3: in the way system stay yeah, exactly the same. And
- 30:03Speaker 3: the level is they can actually estimate, so they estimate
- 30:06Speaker 3: that the average city dweller in Australia is having about
- 30:12Speaker 3: one and a half cigarettes a day and the average
- 30:17Speaker 3: country dweller is having more like two and a half.
- 30:22Speaker 1: So yeah, in terms of nicotine, like the equivalent of the.
- 30:27Speaker 3: Equivalent in order to generate the amount of nicotine they're
- 30:30Speaker 3: finding that that's how it's worked out. So the only
- 30:35Speaker 3: takeaway from that is really that people in the country
- 30:38Speaker 3: smoke or or access nicotine much more frequently than people
- 30:41Speaker 3: in the city. But other than that, it hasn't changed
- 30:46Speaker 3: in ten years.
- 30:47Speaker 1: An interest has changed.
- 30:49Speaker 3: Has a couple of interesting ones. Well, let's talk about
- 30:52Speaker 3: one that's gone down. Alcohol has gone down pretty dramatically, actually.
- 30:58Speaker 1: So that does prize me.
- 31:01Speaker 3: Yeah, so alcohol's dropped from levels. City and country are
- 31:05Speaker 3: both about the same, add around one point three standard
- 31:10Speaker 3: drinks per day per person wow out back in twenty
- 31:15Speaker 3: and thirteen fourteen, and now it's down to around about
- 31:21Speaker 3: The cities are doing a little bit better than the
- 31:23Speaker 3: country on this one as well, but in the city
- 31:26Speaker 3: it's down to about zero point eight of a drink
- 31:29Speaker 3: per day and in the country it's about one per day.
- 31:32Speaker 3: And that's a pretty significant drop over a ten year period,
- 31:36Speaker 3: and it's part of it. It's not just a one off.
- 31:38Speaker 3: It's an ongoing trend of decreasing alcohol consumption, so we're
- 31:41Speaker 3: no longer getting our jollies from alcohol, which makes you wonder, well,
- 31:46Speaker 3: what are we consuming instead of the alcohol any guesses?
- 31:52Speaker 1: Yes, opiates, opioids or whatever. The opiates like painkillers, zanak.
- 31:59Speaker 3: Not so much so oxycodone and fentanyl, which they are
- 32:02Speaker 3: both measured obviously, Yeah, not so much oxycona. Oxycodone has
- 32:08Speaker 3: been about the same the whole time. There was a
- 32:10Speaker 3: little spike in COVID in the country for oxycodone, but
- 32:17Speaker 3: other than that it's been about the same. Fentanyl similar
- 32:20Speaker 3: same spike, about the same time, but pretty much flat
- 32:23Speaker 3: the whole time. Heroin has been increasing lately, so pretty
- 32:30Speaker 3: flat for a while, jumped up a bit during COVID, jumped,
- 32:35Speaker 3: dropped off again, and then it's now sparking back up again.
- 32:39Speaker 3: So in the last round we had a big, big
- 32:42Speaker 3: jump so the country. Well, heroin, by the way, much
- 32:46Speaker 3: more heavily consumed in the city than in the country.
- 32:50Speaker 3: But in the city it dropped up from it jumped
- 32:53Speaker 3: up from about if we look about a year ago,
- 32:57Speaker 3: it jumped up from about eight doses per thousand people
- 33:01Speaker 3: per day to about eleven in the most recent one
- 33:04Speaker 3: in the city, so it's a pretty big jump. And
- 33:07Speaker 3: in the country it's jumped up from about two and
- 33:09Speaker 3: a half doses per person per day up to about
- 33:13Speaker 3: eight and a half so up, yes, that's right.
- 33:18Speaker 1: I mean that is nearly two hundred and something percent.
- 33:23Speaker 3: Yeah, still nowhere near the city, but big jump.
- 33:27Speaker 1: Yeah.
- 33:29Speaker 3: So Heroin has been on the up and up. Cannabis
- 33:34Speaker 3: pretty flat, nothing much going on there, not going up,
- 33:37Speaker 3: not going down as usual a country double the rate
- 33:42Speaker 3: in the country than in the city the rate. So
- 33:47Speaker 3: they're all hitting the hash a little bit harder out
- 33:50Speaker 3: in the country. But it hasn't changed much in ten years,
- 33:54Speaker 3: is that right, Grandpa? Yeah, it is grad prior here anyway.
- 33:59Speaker 3: Kedym jumped up quite a bit in the last round
- 34:03Speaker 3: after not doing much for about a decade and just
- 34:06Speaker 3: lately is chopped. But the big mover, the big mover,
- 34:09Speaker 3: and this is a sixty nine percent increase in a year.
- 34:12Speaker 1: Drum rollative. I feel like we're at the logis it
- 34:15Speaker 1: is and the winner is twenty twenty five big improver
- 34:19Speaker 1: of the year coming out of nowhere.
- 34:23Speaker 3: Cocaine.
- 34:23Speaker 1: Did you say cocaine?
- 34:25Speaker 3: Yeah, that's a big One's an increase.
- 34:29Speaker 1: I'm very ignorant when well, I did used to work
- 34:32Speaker 1: at a rehab but in terms of like I just
- 34:35Speaker 1: used to deal with the people that were dealing with
- 34:37Speaker 1: the stuff, right, But is I don't think either of
- 34:41Speaker 1: you are the one to ask, but maybe you know
- 34:43Speaker 1: more than me. Is cocaine expensive? I feel like that's expensive.
- 34:48Speaker 3: Well, I think it's probably more expensive than other things. Tay.
- 34:55Speaker 2: I normally just yeah, I just let them get access
- 34:58Speaker 2: to my bank account directly, So I'm not sure.
- 35:00Speaker 3: Yeah, he's not sure.
- 35:02Speaker 1: Now yeah, wow, I wouldn't do that. But wow, and
- 35:07Speaker 1: and so what's that gone from what to what?
- 35:10Speaker 3: Ah? Let me have a look at exact numbers here,
- 35:13Speaker 3: so it's yeah, it doesn't feel that big. Hold on,
- 35:17Speaker 3: I'm looking at the wrong graft. That's why here we go.
- 35:21Speaker 3: So it's gone from about six doses per thousand people
- 35:26Speaker 3: per day to ten doses per thousand people per day,
- 35:32Speaker 3: much bigger, much bigger in the city than in the country,
- 35:37Speaker 3: although the country is catching up pretty quickly. So yeah,
- 35:43Speaker 3: So the interesting thing is, Okay, at a at a
- 35:48Speaker 3: sort of big level, well, alcohol is dropping off, but
- 35:52Speaker 3: it's being replaced by much more powerful stimulants. So cocaine
- 35:59Speaker 3: is a notch up from alcohol, and obviously heroin is too.
- 36:04Speaker 3: So you're seeing the nicotine consumption staying flat when we
- 36:11Speaker 3: really think it should be going down. You're seeing alcohol
- 36:14Speaker 3: probably matching people's perception, which is that people are drinking
- 36:17Speaker 3: less these days, but what people are substituting it for
- 36:21Speaker 3: seems to be much harder stuff. So we're talking about
- 36:25Speaker 3: heroin and cocaine and MDMA and MDA and methamphetamines and amphetamines,
- 36:34Speaker 3: so all of these things are on the rights and
- 36:39Speaker 3: that's a real concern. And my theory, without any justification
- 36:42Speaker 3: and certainly no study in the BMJ to prove it,
- 36:45Speaker 3: is if we start addicting the entire population all the
- 36:49Speaker 3: time by giving them access to apps that are engineered
- 36:52Speaker 3: for addiction, like social media and gaming and so on,
- 36:56Speaker 3: then that addiction spills over into everything. You need a better,
- 37:00Speaker 3: stronger hit then you can get from the more normal
- 37:03Speaker 3: things once you are accessing dopamine hits all the time.
- 37:09Speaker 1: Wow, that is interesting. If didn't you tell us on
- 37:12Speaker 1: one episode once you had like half a joint when
- 37:14Speaker 1: you were like seventeen or something. Oh yeah, how what
- 37:19Speaker 1: I can't imagine?
- 37:21Speaker 3: What are you?
- 37:21Speaker 1: And as David calls it hash or the kids call
- 37:25Speaker 1: it true true.
- 37:27Speaker 2: At it twice and one time it was absolutely hilarious.
- 37:30Speaker 2: Best thing ever. Second time will I knowingly had it
- 37:33Speaker 2: because a boyfriend of mine smoked and I smoked cigarettes
- 37:37Speaker 2: at the time, and I thought he just rolled me
- 37:42Speaker 2: a cigarette with his rollies, but he'd put some in
- 37:45Speaker 2: it and then was laughing, well, waiting for you to
- 37:48Speaker 2: kick in. And I hate it, hate it?
- 37:52Speaker 3: And what about you find? Are you find coke much better?
- 37:57Speaker 2: Coke's much better? I'm on that daily.
- 37:59Speaker 1: Yeah, they're speaking of coke. Nothing to do. We'll come
- 38:04Speaker 1: back to the topic at hand. But did you see
- 38:06Speaker 1: the I don't know who it was. They put out
- 38:10Speaker 1: a thing the other day saying that it was on
- 38:12Speaker 1: the news, which is always a dubious source of scientific information.
- 38:18Speaker 1: But anyway, they're talking about how having sweetness, artificial sweetness
- 38:26Speaker 1: increase so soft drinks increases the chance of diabetes by
- 38:31Speaker 1: type two diabetes by something like thirty six percent versus
- 38:34Speaker 1: sugar twenty three percent. Did you see that?
- 38:37Speaker 3: I did. It inspired me to go and have a
- 38:39Speaker 3: look at the study. I wasn't too impressed with the
- 38:42Speaker 3: study actually, because they didn't ad just for the weight
- 38:47Speaker 3: of the person, so and the fact that there's a
- 38:52Speaker 3: high probability that most people who are consuming artificial sweeteners
- 38:56Speaker 3: are probably also consuming sugar. So it's not like people
- 39:01Speaker 3: just decide I'm never touching sugar again in my life.
- 39:04Speaker 3: I'm just having artificial sweetness. But it was an interesting
- 39:07Speaker 3: study because it did at least raise the question because
- 39:12Speaker 3: what seemed to what the study seemed to be saying
- 39:14Speaker 3: is if you have artificial sweetness instead of sugar, it
- 39:18Speaker 3: doesn't change your risk of type two diabetes, and that
- 39:21Speaker 3: it's bad with sugar and it's still bad with artificial sweetness.
- 39:25Speaker 3: It does, however, change your risk of being fat. So
- 39:29Speaker 3: that was an interesting thing. It didn't it meant that
- 39:34Speaker 3: the type two diabetes risk wasn't altered by the fact
- 39:37Speaker 3: that you were thin if you were consuming artificial sweetness. Honestly,
- 39:42Speaker 3: I felt the methodology in the study left a lot
- 39:46Speaker 3: of room for improvement because of the things I mentioned
- 39:48Speaker 3: before about what you included and excluded. Nevertheless, it does
- 39:54Speaker 3: pose an interesting question, is there something going on there
- 39:58Speaker 3: where we tell our body to expect sweetness and then
- 40:01Speaker 3: don't deliver it, don't deliver the calories, which would cause
- 40:05Speaker 3: you to going weight, but the body still expects the
- 40:07Speaker 3: sweetness and makes an adjustment. That's an interesting area. And yeah,
- 40:13Speaker 3: so I felt the study was interesting for that reason.
- 40:15Speaker 1: I'd like to look at somebody with, you know, on
- 40:19Speaker 1: an empty stomach, high Grellen levels or whatever, and get
- 40:23Speaker 1: both of them to have a can of regular sugar
- 40:26Speaker 1: coke versus no sugar coke and see whether or not
- 40:30Speaker 1: there's a comparable insulin response to Yeah, I'd like to
- 40:36Speaker 1: see what that is. I wonder if you know, because
- 40:39Speaker 1: obviously you would think with a no sugar drink there'd
- 40:41Speaker 1: be minimal, if any insulin response, but maybe that's not
- 40:45Speaker 1: the case.
- 40:46Speaker 3: Yeah, maybe it would be interesting. I don't understand why
- 40:51Speaker 3: those kinds of studies aren't being done, or if they are,
- 40:53Speaker 3: why they're not being published, because I haven't seen anything
- 40:57Speaker 3: that says that kind of thing. Maybe when you start
- 41:00Speaker 3: the Harps Research Institute, you can that could be studying
- 41:04Speaker 3: number one. You off, get up and running the other
- 41:08Speaker 3: interesting Harper Institute.
- 41:09Speaker 1: That'd be hilarious.
- 41:11Speaker 3: Go go the other one, just a quick one. Did
- 41:13Speaker 3: you see they've got a pill for a zimpic now,
- 41:16Speaker 3: so using the the GLP one stuff rather than having
- 41:19Speaker 3: to inject it just a once daily pill. It's in
- 41:22Speaker 3: trials at the moment and does it not quite as
- 41:24Speaker 3: effective as a zempic, but still still makes you nauseous
- 41:27Speaker 3: enough not to eat.
- 41:29Speaker 1: I have an interesting story about that that I cannot
- 41:32Speaker 1: tell you on the show, but I will tell you
- 41:33Speaker 1: when we finish TIFFs. Looking at me, mate, always good
- 41:40Speaker 1: to chat with you. Let's wind up so I can
- 41:42Speaker 1: tell you that little story. But we appreciate you and
- 41:46Speaker 1: you listeners, and also just go to the New Project
- 41:49Speaker 1: Facebook page and tell me what you think we might
- 41:53Speaker 1: do for the two thousandth episode. I'm leaning towards something
- 41:57Speaker 1: live so we can have a bit of interaction, a
- 41:59Speaker 1: little bit of fun and a bit of a reflection,
- 42:01Speaker 1: and I'd suggest it might go for longer than an
- 42:04Speaker 1: hour or an hour and a half and we'll just
- 42:07Speaker 1: waffle on and then if anyone wants to actually listen
- 42:09Speaker 1: to it, they can. If they want to skip it
- 42:11Speaker 1: and go to two thousand and one, they can also
- 42:13Speaker 1: do that.
- 42:13Speaker 3: TIF.
- 42:14Speaker 1: We appreciate you, Thank you, thanks lads, Thanks Bilspo pleasure